Dr. Stuart Gold's patients describe him as both compassionate and weird. You'll have to watch the video to see what they mean by "weird." But in terms of compassion, Gold gives a lot of his time and energy outside of the clinic to promoting awareness of childhood cancer and raising much needed research funds.
Tacrolimus, a drug that is commonly used to prevent organ transplantation rejection, inhibits breast cancer growth in pre-clinical studies. The finding from UNC scientists was reported in the May 26 Public Library of Science.
The UNC team used a statewide database to collect information on over 35,000 Emergency department (ED) visits. They learned that the top three problems that brought patients to the ED were related to pain, respiratory distress, and gastrointestinal issues (mostly nausea and vomiting).
A UNC study has joined the ranks of an elite group of programs recognized for their contributions to reducing cancer.
An unusual collaboration between cell and developmental biologists and physicists at UNC-Chapel Hill is providing insights into the relationship between the physical properties of cells and the signals that influence cell behavior.
A team based at North Carolina Central University (NCCU) and UNC Lineberger Comprehensive Cancer Center has established a connection between a known cancer gene called KRAS and a protein called Pim-1 kinase.
Researchers at the University of North Carolina at Chapel Hill School of Medicine, after isolating normal stem cells that form the developing placenta, have given them the same properties of stem cells associated with an aggressive type of breast cancer.
Samuel Cykert, MD, has received a $1.8 million five-year grant from the American Cancer Society (ACS) to study “Lung Cancer Surgery: Decisions Against Life Saving Care.”
Research led by UNC School of Medicine scientists finds that a "promiscuous DNA replication process" may be responsible for large-scale genome duplications in developing tumors.
A gallery showing in May will be the culmination of this expressive photography project and support group for teen cancer survivors that has taken place over nine months of meetings, sharing and photography.
Andrew Wang, MD, assistant professor of radiation oncology, has been awarded a $100,000 one-year grant from the National Academies Keck Futures Initiative (NAKFI), a program of the National Academy of Sciences, the National Academy of Engineering, and the Institute of Medicine with support from the W.M. Keck Foundation.
Jessica Breland is at the top of her game. She is now the 16th Carolina Women's Basketball player in school history to be selected for the WNBA draft, which took place this year on Monday, April 11. Breland was the 13th pick overall, and next year she'll be playing for the New York Liberty. But Breland doesn't take anything for granted. She had to sit out the 2009 - 2010 season while undergoing treatment for Hodgkin’s lymphoma at UNC.
The life-threatening illnesses of their first-born children unite two couples in a friendship that each expects to bind them the rest of their days.
New research from the University of North Carolina at Chapel Hill School of Medicine adds clarity to the connection. The study published on-line April 10th in the journal Nature Immunology finds that saturated fatty acids but not the unsaturated type can activate immune cells to produce an inflammatory protein, called interleukin-1beta.
Angelique Whitehurst, PhD, assistant professor of pharmacology and a member of UNC Lineberger Comprehensive Cancer Center, has been awarded one of 13 Innovative Research Grants from Stand Up to Cancer, the scientific partner of the American Association of Cancer Research.
This conference will take place in Kitty Hawk, NC, May 13 - 14. This course is designed to provide data-driven and practical recommendations to clinicians, patients and caregivers for coping with the challenges of cancer.
UNC biochemist Yi Zhang, PhD, whose team conducted the studies, called the findings an important step in understanding the molecular mechanisms behind cell differentiation and the development of cancer.
The study is sponsored by UNC Lineberger and financially supported by Bayer HealthCare AG, which will provide study medication free of charge to patients enrolled on the trial.
The grant will fund laboratory research to test whether a new class of drugs called PARP-inhibitors, which have successfully been used to treat other types of cancers, along with nanoparticle anti-cancer agents may be effective in treating brain metastases from triple-negative breast cancer.
The UNC Supportive Care and Consult Service and Clinic’s innovative model of a pharmacist as part of the care team in the outpatient setting continues to attract national attention and interest.